In the UK, the forecast for pancreas malignant neoplasms mortality in males indicates an upward trend from 2024 to 2028. The mortality figures, expressed in thousands, are predicted to increase steadily. From 2024 to 2025, there is a year-on-year growth of approximately 1.66%, while from 2025 to 2026, the increase is around 1.45%. This pattern continues with 2026 to 2027 showing a rise of 1.43%, and 2027 to 2028 with an increase of 1.41%. The five-year compound annual growth rate (CAGR) stands at 1.48%.
For future trends, monitoring advances in early detection and treatment strategies could impact these forecasts. Government health policies and public health initiatives aimed at reducing risk factors like smoking and unhealthy diets may also play crucial roles in altering future mortality trends.
